Evidence map›Paper›PMID 31591399›Full record

ArticleNature communications2019

Author Correction: Hsp70 and Hsp40 inhibit an inter-domain interaction necessary for transcriptional activity in the androgen receptor.

Bahareh Eftekharzadeh, Varuna C Banduseela, Giulio Chiesa, Paula Martínez-Cristóbal, Jennifer N Rauch, Samir R Nath, Daniel M C Schwarz, Hao Shao, Marta Marin-Argany, Claudio Di Sanza and 10 more

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 82% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors at 5 institutions in 3 countries.

Bahareh EftekharzadehInstitute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Baldiri Reixac 10, 08028, Barcelona, Spain.
Varuna C BanduseelaDepartment of Pathology, University of Michigan, Ann Arbor, MI, 48109, USA.
Giulio ChiesaInstitute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Baldiri Reixac 10, 08028, Barcelona, Spain.
Paula Martínez-CristóbalInstitute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Baldiri Reixac 10, 08028, Barcelona, Spain.
Jennifer N RauchUniversity of California at San Francisco, Department of Pharmaceutical Chemistry, 675 Nelson Rising Lane, San Francisco, CA, 94158, USA.
Samir R NathDepartment of Pathology, University of Michigan, Ann Arbor, MI, 48109, USA.
Daniel M C SchwarzUniversity of California at San Francisco, Department of Pharmaceutical Chemistry, 675 Nelson Rising Lane, San Francisco, CA, 94158, USA.
Hao ShaoUniversity of California at San Francisco, Department of Pharmaceutical Chemistry, 675 Nelson Rising Lane, San Francisco, CA, 94158, USA.
Marta Marin-ArganyInstitute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Baldiri Reixac 10, 08028, Barcelona, Spain.
Claudio Di SanzaInstitute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Baldiri Reixac 10, 08028, Barcelona, Spain.
Elisa GiorgettiDepartment of Pathology, University of Michigan, Ann Arbor, MI, 48109, USA.ORCID http://orcid.org/0000-0001-7960-0663
Zhigang YuDepartment of Pathology, University of Michigan, Ann Arbor, MI, 48109, USA.
Roberta PierattelliCERM and Department of Chemistry "Ugo Schiff", University of Florence, Via Luigi Sacconi 6, 50019 Sesto Fiorentino, Florence, Italy.ORCID http://orcid.org/0000-0001-7755-0885
Isabella C FelliCERM and Department of Chemistry "Ugo Schiff", University of Florence, Via Luigi Sacconi 6, 50019 Sesto Fiorentino, Florence, Italy.ORCID http://orcid.org/0000-0002-6018-9090
Isabelle Brun-HeathInstitute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Baldiri Reixac 10, 08028, Barcelona, Spain.
Jesús GarcíaInstitute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Baldiri Reixac 10, 08028, Barcelona, Spain.ORCID http://orcid.org/0000-0003-2961-9790
Ángel R NebredaInstitute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Baldiri Reixac 10, 08028, Barcelona, Spain.
Jason E GestwickiUniversity of California at San Francisco, Department of Pharmaceutical Chemistry, 675 Nelson Rising Lane, San Francisco, CA, 94158, USA. jason.gestwicki@ucsf.edu.ORCID http://orcid.org/0000-0002-6125-3154
Andrew P LiebermanDepartment of Pathology, University of Michigan, Ann Arbor, MI, 48109, USA. liebermn@umich.edu.
Xavier SalvatellaInstitute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Baldiri Reixac 10, 08028, Barcelona, Spain. xavier.salvatella@irbbarcelona.org.ORCID http://orcid.org/0000-0002-8371-4185
Institute for Research in Biomedicine · ESUniversity of Michigan · USUniversity of California, San Francisco · USInstitució Catalana de Recerca i Estudis Avançats · ESUniversity of Florence · IT

Funding

RESEARCH TRAINING IN CHEMISTRY AND CHEMICAL BIOLOGYT32GM064337 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CRAIK, CHARLES SCOTT · 2002 to 2021
$7.8M
NIGMS NIH HHS T32 GM064337
6 · The paper itself

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiers

PMID31591399
PMCPMC6779909
OpenAlexW2977746146

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.